Home > Insider Trading > Filing (0001387131-18-004753)

Filing Details

Accession Number:: 0001387131-18-004753
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-09-14 19:34:57
Reporting Period:: 2018-09-12

Accepted Time:: 2018-09-14 19:34:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
25743	Therapeuticsmd Inc.	TXMD	Pharmaceutical Preparations (2834)	870233535

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1532233	Brian Bernick	6800 Broken Sound Pkwy Nw, Third Floor Boca Raton FL 33487		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-12	91,400	$0.10	6,648,771	No	4	M	Indirect	By BF Investment Enterprises, Ltd.
Common Stock	Disposition	2018-09-12	91,400	$6.26	6,557,371	No	4	S	Indirect	By BF Investment Enterprises, Ltd.
Common Stock	Acquisiton	2018-09-13	91,400	$0.10	6,648,771	No	4	M	Indirect	By BF Investment Enterprises, Ltd.
Common Stock	Disposition	2018-09-13	91,400	$6.35	6,557,371	No	4	S	Indirect	By BF Investment Enterprises, Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	By BF Investment Enterprises, Ltd.
No	4	S	Indirect	By BF Investment Enterprises, Ltd.
No	4	M	Indirect	By BF Investment Enterprises, Ltd.
No	4	S	Indirect	By BF Investment Enterprises, Ltd.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2018-09-12	91,400	$0.00	91,400	$0.10
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2018-09-13	91,400	$0.00	91,400	$0.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,371,510	2012-01-01	2019-01-01	No	4	M	Indirect
1,280,110	2012-01-01	2019-01-01	No	4	M	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	242,000	Direct
Common Stock	3,000	Indirect	By BF Management, LLC

Footnotes

The reported securities are owned by BF Investment Enterprises, Ltd. ("BF Investment"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the "GP"), the general partner of BF Investment, (ii) holds, togetherwith his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.34, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.43, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported securities are held by the GP. As disclosed in footnote 1 above, the Reporting Person, together with his spouse as tenants by the entirety, holds a 70.6% membership interest in the GP. The Reporting Person disclaims beneficial ownership of the reported securities held by the GP, except to the extent of his pecuniary interest therein.